Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| LER-H5252 | Human | Human Leptin R / CD295 Protein, Fc Tag |  |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Metreleptin | KTR-103; AC-164594 | Approved | Amylin Pharmaceutical, Bristol-Myers Squibb Company, Astrazeneca Plc | Metreleptin [SHIONOGI], Myalepta | EU | Lipodystrophy | Amryt Pharmaceuticals Dac | 2013-03-25 | HIV Infections; Diabetes Mellitus, Type 1; Non-alcoholic Fatty Liver Disease; Insulin Resistance; Metabolic Syndrome; Lipodystrophy; Obesity; Lipodystrophy, Familial Partial; Lipodystrophy, Congenital Generalized; Lipomatosis, Multiple Symmetrical; Overweight; Diabetes Mellitus; Hyperlipidemias | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Mibavademab | REGN-4461 | Phase 2 Clinical | Regeneron Pharmaceuticals Inc | Lipodystrophy, Congenital Generalized; Lipodystrophy, Familial Partial; Lipid Metabolism Disorders | Details |
This web search service is supported by Google Inc.
A-Z
